EA2-14411-12734
1 vaccination
4 coded responses
5 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 666 / KS
- Registered
- 2021-08-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-28
Dose 1 — Pfizer-BioNTech
-
2021-08-16
Registered in v-safe
-
2021-08-16
Survey response — day 14, dose 1MedDRA: Ear pain, Heart rate increased, Injection site swelling, Lymphadenopathy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Rapid heart rate first four or five days now intermittent. Very swollen arm at site. Then started with earache and swollen lymph nodes in neck, below ear and left jaw lineMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Survey response — day 28, dose 1MedDRA: Extrasystoles, Lymphadenopathy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Skipped heart beats for four or five days. Very swollen lymph nodes in my neckMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-27
Survey response — 3 months, dose 1MedDRA: Arrhythmia, Contusion, Fatigue, Lymphadenopathy, Ventricular extrasystoles — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: The lymphadenopathy is much improved with one persistent swollen node in the back of neck I have had worsening symptomatic arrhythmias. PVCS Many! I have been put on metoprolol to decrease symptomolgy Bruising, spont Resolved. ExhaustionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-01
-
2022-01-26
Survey response — 6 months, dose 1MedDRA: Arrhythmia, Lymphadenopathy, Therapeutic product ineffective, Ventricular extrasystoles, Ventricular tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Afib? Getting ready for two week heart monitoring. NSVT and PVC's treated with toprolol with unsuccessful tapering. Arrrythmias persist. Swollen node in back of neck still remains.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 6 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-27
Call successfulReported to VAERS during previous contact from GDIT
- 2022-07-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-28 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 9 — day 14, dose 1
Symptoms: Rapid heart rate first four or five days now intermittent. Very swollen arm at site. Then started with earache and swollen lymph nodes in neck, below ear and left jaw line
Release 9 — day 28, dose 1
Symptoms: Skipped heart beats for four or five days. Very swollen lymph nodes in my neck
Release 10 — 3 months, dose 1
Symptoms: The lymphadenopathy is much improved with one persistent swollen node in the back of neck I have had worsening symptomatic arrhythmias. PVCS Many! I have been put on metoprolol to decrease symptomolgy Bruising, spont Resolved. Exhaustion
Release 11 — 6 months, dose 1
Symptoms: Afib? Getting ready for two week heart monitoring. NSVT and PVC's treated with toprolol with unsuccessful tapering. Arrrythmias persist. Swollen node in back of neck still remains.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arrhythmia | · | · | ✓ |
| SD | Contusion | · | · | ✓ |
| SD | Ear pain | ✓ | · | ✓ |
| SD | Extrasystoles | ✓ | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | ✓ | · | ✓ |
| SD | Injection site swelling | ✓ | · | ✓ |
| SD | Lymphadenopathy | ✓ | · | ✓ |
| SD | Therapeutic product ineffective | · | · | ✓ |
| SD | Ventricular extrasystoles | · | · | ✓ |
| SD | Ventricular tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release